Comment on ???The Economics of Follow-On Drug Research and Development: Trends in Entry Rates and the Timing of Development???

This publication has 10 references indexed in Scilit:

• Influence of Patients’ Requests for Direct-to-Consumer Advertised Antidepressants
  JAMA, 2005
• Are novel drugs more risky for patients than less novel drugs?
  Journal of Health Economics, 2004
• The Economics of Follow-on Drug Research and Development
  PharmacoEconomics, 2004
• Pharmaceutical Pricing in a Regulated Market
  The Review of Economics and Statistics, 2003
• Do Pharmaceutical Sales Respond to Scientific Evidence?
  Journal of Economics & Management Strategy, 2002
• The Dual Effects of Intellectual Property Regulations: Within‐ and Between‐Patent Competition in the U.S. Pharmaceuticals Industry
  The Journal of Law and Economics, 2002
• The Orphan Drug Act: an engine of innovation? At what cost?
  2000
• Strategic Pricing of New Pharmaceuticals
  The Review of Economics and Statistics, 1998
• Oligopolistic Competition and the Optimal Provision of Products
  Econometrica, 1995
• Product Selection, Fixed Costs, and Monopolistic Competition
  The Review of Economic Studies, 1976